Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute
  • Patient-Centered Outcomes Research Institute

This publication has 29 references indexed in Scilit: